2023 Q1 Form 10-K Financial Statement
#000182912623002428 Filed on March 30, 2023
Income Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $263.4K | $116.5K | $398.8K |
YoY Change | 7320.28% | 1166.74% | 1504.88% |
Operating Profit | -$263.4K | -$398.8K | |
YoY Change | 7320.23% | ||
Interest Expense | $858.9K | $992.7K | $1.673M |
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | $858.9K | $1.673M | |
YoY Change | |||
Pretax Income | $595.5K | $876.1K | $1.275M |
YoY Change | -16874.7% | -9622.93% | -5229.45% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | $595.5K | $876.1K | $1.275M |
YoY Change | -16874.7% | -9622.93% | -5229.45% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | $0.07 | $0.06 | $0.09 |
COMMON SHARES | |||
Basic Shares Outstanding | 8.820M shares | 14.71M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $58.20M | $116.9M | $116.7M |
YoY Change | 121648.87% | ||
Cash & Equivalents | $0.00 | $178.7K | |
Short-Term Investments | $58.20M | $116.7M | $116.7M |
Other Short-Term Assets | $133.2K | $218.3K | $218.3K |
YoY Change | -67.64% | -34.34% | -34.34% |
Inventory | |||
Prepaid Expenses | $39.68K | ||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $58.33M | $116.9M | $116.9M |
YoY Change | 14071.15% | 35055.43% | 35055.43% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | -$1.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $58.33M | $116.9M | $116.9M |
Total Long-Term Assets | -$1.00 | $0.00 | $0.00 |
Total Assets | $58.33M | $116.9M | $116.9M |
YoY Change | 14071.15% | 35055.43% | 35055.43% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | $289.1K | $146.7K | $146.7K |
YoY Change | 151.34% | 18242.25% | 353.6% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $793.6K | $0.00 | $0.00 |
YoY Change | 164.52% | -100.0% | -100.0% |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $3.958M | $3.022M | $3.022M |
YoY Change | 853.57% | 809.2% | 809.2% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $3.958M | $3.022M | $3.022M |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $3.958M | $3.022M | $3.022M |
YoY Change | 853.57% | 809.2% | 809.2% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$3.828M | -$2.807M | |
YoY Change | 11194.2% | ||
Common Stock | $3.205K | $3.205K | |
YoY Change | 11.48% | 11.48% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$3.824M | -$2.803M | $113.9M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $58.33M | $116.9M | $116.9M |
YoY Change | 14071.15% | 35055.43% | 35055.43% |
Cashflow Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $595.5K | $876.1K | $1.275M |
YoY Change | -16874.7% | -9622.93% | -5229.45% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$82.16K | -$9.750K | -$87.59K |
YoY Change | 96.32% | -92.2% | -61.76% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $59.33M | $0.00 | -$115.0M |
YoY Change | |||
Cash From Investing Activities | $59.33M | $0.00 | -$115.0M |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $114.7M | ||
YoY Change | 458700.0% | ||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -$59.30M | 0.000 | $115.2M |
YoY Change | 35337.0% | ||
NET CHANGE | |||
Cash From Operating Activities | -$82.16K | -9.750K | -$87.59K |
Cash From Investing Activities | $59.33M | 0.000 | -$115.0M |
Cash From Financing Activities | -$59.30M | 0.000 | $115.2M |
Net Change In Cash | -$46.28K | -9.750K | $82.67K |
YoY Change | 10.59% | -92.2% | -13.86% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$82.16K | -$9.750K | -$87.59K |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001882464 | |
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2021Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
usd | |
CY2021Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
usd | |
CY2022Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
usd | |
CY2022Q4 | MSSAU |
Accrued Offering Costs
AccruedOfferingCosts
|
usd | |
CY2022Q4 | MSSAU |
Promissory Note Related Party
PromissoryNoteRelatedParty
|
usd | |
CY2021Q4 | MSSAU |
Deferred Underwriting Commission
DeferredUnderwritingCommission
|
usd | |
CY2021Q4 | us-gaap |
Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
|
usd | |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
usd | |
us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
usd | ||
us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
usd | ||
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
usd | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | ||
MSSAU |
Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Subject To Possible Redemption
BasicAndDilutedWeightedAverageSharesOutstandingOrdinarySharesSubjectToPossibleRedemption
|
shares | ||
MSSAU |
Basic And Diluted Net Income Loss Per Share Ordinary Shares Subject To Redemption
BasicAndDilutedNetIncomeLossPerShareOrdinarySharesSubjectToRedemption
|
|||
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
usd | |
MSSAU |
Cancellation Of Founder Share To Sponsor
CancellationOfFounderShareToSponsor
|
usd | ||
MSSAU |
Interest Earned In Trust Account
InterestEarnedInTrustAccount
|
usd | ||
MSSAU |
Unrealized Gain On Marketable Securities Held In Trust Account
UnrealizedGainOnMarketableSecuritiesHeldInTrustAccount
|
usd | ||
us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
usd | ||
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
usd | ||
us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
usd | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | ||
CY2022 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
usd | |
CY2022 | MSSAU |
Proceeds From Issuance Of Founder Shares To Sponsor
ProceedsFromIssuanceOfFounderSharesToSponsor
|
usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
usd | ||
MSSAU |
Payment Of Offering Costs
PaymentOfOfferingCosts
|
usd | ||
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
usd | |
CY2022 | MSSAU |
Deferred Offering Cost Included In Accrued Offering Costs
DeferredOfferingCostIncludedInAccruedOfferingCosts
|
usd | |
MSSAU |
Defer Underwriting Compensation
DeferUnderwritingCompensation
|
usd | ||
MSSAU |
Initial Ordinary Share Subject To Possible Redemption
InitialOrdinaryShareSubjectToPossibleRedemption
|
usd | ||
MSSAU |
Reclassification Of Offering Costs Related To Public Shares
ReclassificationOfOfferingCostsRelatedToPublicShares
|
usd | ||
MSSAU |
Change In Value Of Ordinary Costs Related To Public Shares
ChangeInValueOfOrdinaryCostsRelatedToPublicShares
|
usd | ||
MSSAU |
Subsequent Measurement Of Ordinary Shares Subject To Redemption Interest Earned And Unrealized Gain On Trust Account
SubsequentMeasurementOfOrdinarySharesSubjectToRedemptionInterestEarnedAndUnrealizedGainOnTrustAccount
|
usd | ||
CY2022 | dei |
Document Type
DocumentType
|
10-K | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3021738 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
332350 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
3021738 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
332350 | usd |
CY2022Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
11500000 | shares |
CY2022 | dei |
Entity File Number
EntityFileNumber
|
001-41344 | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
METAL SKY STAR ACQUISITION CORPORATION | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
E9 | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
00-0000000 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
132 West 31st Street | |
CY2022 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
9th Floor | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
New York | |
CY2022 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | |
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10001 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
(332) | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
237-6141 | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2022 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2022 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
true | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
113735000 | usd |
CY2023Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
8819676 | shares |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
1195 | |
CY2022 | dei |
Auditor Name
AuditorName
|
UHY LLP | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
New York, New York | |
CY2022Q4 | MSSAU |
Cash Held In Escrow
CashHeldInEscrow
|
178652 | usd |
CY2021Q4 | MSSAU |
Cash Held In Escrow
CashHeldInEscrow
|
95978 | usd |
CY2022Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
39683 | usd |
CY2022Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
116673481 | usd |
CY2021Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
236522 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
116891816 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
332500 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
116891816 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
332500 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
146738 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
800 | usd |
CY2021Q4 | MSSAU |
Accrued Offering Costs
AccruedOfferingCosts
|
31550 | usd |
CY2021Q4 | MSSAU |
Promissory Note Related Party
PromissoryNoteRelatedParty
|
300000 | usd |
CY2022Q4 | MSSAU |
Deferred Underwriting Commission
DeferredUnderwritingCommission
|
2875000 | usd |
CY2021Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
11500000 | shares |
CY2022Q4 | us-gaap |
Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
|
116673481 | usd |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3205000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
3205000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2875000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2875000 | shares |
CY2022Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
11500000 | shares |
CY2021Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
11500000 | shares |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
3205 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
2875 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
22125 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-2806608 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-24850 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2803403 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
150 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
116891816 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
332500 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
398812 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
24850 | usd | |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-398812 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-24850 | usd | |
CY2022 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-398812 | usd |
us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-24850 | usd | |
CY2022 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
1295815 | usd |
CY2022 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
377666 | usd |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1673481 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1274669 | usd |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-24850 | usd | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1274669 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-24850 | usd | |
CY2022 | MSSAU |
Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Subject To Possible Redemption
BasicAndDilutedWeightedAverageSharesOutstandingOrdinarySharesSubjectToPossibleRedemption
|
8538356 | shares |
CY2022 | MSSAU |
Basic And Diluted Net Income Loss Per Share Ordinary Shares Subject To Redemption
BasicAndDilutedNetIncomeLossPerShareOrdinarySharesSubjectToRedemption
|
0.75 | |
CY2022 | MSSAU |
Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Not Subject To Possible Redemption
BasicAndDilutedWeightedAverageSharesOutstandingOrdinarySharesNotSubjectToPossibleRedemption
|
3120014 | shares |
MSSAU |
Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Not Subject To Possible Redemption
BasicAndDilutedWeightedAverageSharesOutstandingOrdinarySharesNotSubjectToPossibleRedemption
|
2500000 | shares | |
CY2022 | MSSAU |
Basic And Diluted Net Income Loss Per Share Non Redeemable Ordinary Shares Subject To Redemption
BasicAndDilutedNetIncomeLossPerShareNonRedeemableOrdinarySharesSubjectToRedemption
|
-1.65 | |
MSSAU |
Basic And Diluted Net Income Loss Per Share Non Redeemable Ordinary Shares Subject To Redemption
BasicAndDilutedNetIncomeLossPerShareNonRedeemableOrdinarySharesSubjectToRedemption
|
-0.01 | ||
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
150 | usd |
CY2022 | MSSAU |
Issuance Of Public Shares At Initial Public Offering
IssuanceOfPublicSharesAtInitialPublicOffering
|
115000000 | usd |
CY2022 | MSSAU |
Underwriters Discount
UnderwritersDiscount
|
-5175000 | usd |
CY2022 | MSSAU |
Offering Costs
OfferingCosts
|
-529741 | usd |
CY2022 | MSSAU |
Sale Of Shares To Sponsor In Private Placement
SaleOfSharesToSponsorInPrivatePlacement
|
3300000 | usd |
CY2022 | MSSAU |
Initial Value Of Ordinary Stock Subject To Possible Redemption
InitialValueOfOrdinaryStockSubjectToPossibleRedemption
|
-101200000 | usd |
CY2022 | MSSAU |
Allocation Of Offering Costs Related To Redeemable Shares
AllocationOfOfferingCostsRelatedToRedeemableShares
|
5020172 | usd |
CY2022 | MSSAU |
Accretion Of Carrying Value Of Redeemable Shares To Redemption Value
AccretionOfCarryingValueOfRedeemableSharesToRedemptionValue
|
-18820172 | usd |
CY2022 | MSSAU |
Subsequent Measurement Of Ordinary Shares Subject To Redemption Interest Earned And Unrealized Gain On Trust Account
SubsequentMeasurementOfOrdinarySharesSubjectToRedemptionInterestEarnedAndUnrealizedGainOnTrustAccount
|
-1673481 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
1274669 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2803403 | usd |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
25000 | usd | |
MSSAU |
Repurchase Of Founder Shares
RepurchaseOfFounderShares
|
-25000 | usd | |
us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
25000 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
-24850 | usd | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
150 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1274669 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-24850 | usd | |
CY2022 | MSSAU |
Interest Earned In Trust Account
InterestEarnedInTrustAccount
|
1295815 | usd |
CY2022 | MSSAU |
Unrealized Gain On Marketable Securities Held In Trust Account
UnrealizedGainOnMarketableSecuritiesHeldInTrustAccount
|
377666 | usd |
CY2022 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
117817 | usd |
CY2022 | MSSAU |
Increase Decrease In Deferred Offering Costs
IncreaseDecreaseInDeferredOfferingCosts
|
-236522 | usd |
MSSAU |
Increase Decrease In Deferred Offering Costs
IncreaseDecreaseInDeferredOfferingCosts
|
236522 | usd | |
CY2022 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
157500 | usd |
CY2022 | MSSAU |
Increase Decrease In Accrued Offering Costs
IncreaseDecreaseInAccruedOfferingCosts
|
-31550 | usd |
MSSAU |
Increase Decrease In Accrued Offering Costs
IncreaseDecreaseInAccruedOfferingCosts
|
31550 | usd | |
CY2022 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
145938 | usd |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
800 | usd | |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-87585 | usd |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-229022 | usd | |
CY2022 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
115000000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-115000000 | usd |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
300000 | usd | |
MSSAU |
Proceeds From Issuance Of Founder Shares To Sponsor
ProceedsFromIssuanceOfFounderSharesToSponsor
|
25000 | usd | |
CY2022 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
3300000 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
114700000 | usd |
CY2022 | MSSAU |
Payment Of Offering Costs
PaymentOfOfferingCosts
|
-2829741 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
115170259 | usd |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
325000 | usd | |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
82674 | usd |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
95978 | usd | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
95978 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
178652 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
95978 | usd |
MSSAU |
Deferred Offering Cost Included In Accrued Offering Costs
DeferredOfferingCostIncludedInAccruedOfferingCosts
|
31550 | usd | |
CY2022 | MSSAU |
Defer Underwriting Compensation
DeferUnderwritingCompensation
|
2875000 | usd |
CY2022 | MSSAU |
Initial Ordinary Share Subject To Possible Redemption
InitialOrdinaryShareSubjectToPossibleRedemption
|
101200000 | usd |
CY2022 | MSSAU |
Reclassification Of Offering Costs Related To Public Shares
ReclassificationOfOfferingCostsRelatedToPublicShares
|
-5020172 | usd |
CY2022 | MSSAU |
Change In Value Of Ordinary Costs Related To Public Shares
ChangeInValueOfOrdinaryCostsRelatedToPublicShares
|
18820172 | usd |
CY2022 | MSSAU |
Subsequent Measurement Of Ordinary Shares Subject To Redemption Interest Earned And Unrealized Gain On Trust Account
SubsequentMeasurementOfOrdinarySharesSubjectToRedemptionInterestEarnedAndUnrealizedGainOnTrustAccount
|
-1673481 | usd |
CY2022Q2 | MSSAU |
Proceeds From Ipo And Private Placement
ProceedsFromIpoAndPrivatePlacement
|
115682250 | usd |
CY2022Q2 | MSSAU |
Escrow Cash Transfered
EscrowCashTransfered
|
115000000 | usd |
CY2022Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
116673481 | usd |
CY2021Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
0 | usd |
CY2022Q2 | MSSAU |
Subscription Of Ordinary Shares
SubscriptionOfOrdinaryShares
|
25000 | usd |
CY2022Q2 | MSSAU |
Proceeds From Ipo And Private Placement
ProceedsFromIpoAndPrivatePlacement
|
115682250 | usd |
CY2022Q4 | MSSAU |
Cash Held In Escrow
CashHeldInEscrow
|
178652 | usd |
CY2022 | MSSAU |
Common Stock Subject To Possible Redemption
CommonStockSubjectToPossibleRedemption
|
116673481 | usd |
CY2021Q4 | MSSAU |
Cash Held In Escrow
CashHeldInEscrow
|
95978 | usd |
CY2022Q4 | us-gaap |
Marketable Securities
MarketableSecurities
|
116673481 | usd |
CY2021Q4 | us-gaap |
Marketable Securities
MarketableSecurities
|
0 | usd |
CY2022Q4 | MSSAU |
Deferred Underwriting Commissions
DeferredUnderwritingCommissions
|
2875000 | usd |
CY2021Q4 | MSSAU |
Deferred Underwriting Commissions
DeferredUnderwritingCommissions
|
0 | usd |
CY2022Q4 | us-gaap |
Cash
Cash
|
178652 | usd |
CY2022Q4 | MSSAU |
Working Capital
WorkingCapital
|
71597 | usd |
CY2022Q4 | us-gaap |
Marketable Securities
MarketableSecurities
|
116673481 | usd |
CY2022Q4 | MSSAU |
Deferred Underwriting Commissions
DeferredUnderwritingCommissions
|
2875000 | usd |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84D_eus-gaap--UseOfEstimates_zaDJDGHyrOdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_z5DoUG1426V">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> | |
CY2022Q4 | MSSAU |
Cash Held In Escrow
CashHeldInEscrow
|
178652 | usd |
CY2021Q4 | MSSAU |
Cash Held In Escrow
CashHeldInEscrow
|
95978 | usd |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1673481 | usd |
CY2022 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
1295815 | usd |
CY2022 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
377666 | usd |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | usd |
CY2022Q4 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | usd |
CY2021Q4 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | usd |
CY2022 | MSSAU |
Warrants Exercisable
WarrantsExercisable
|
5915000 | shares |
CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zKgnXDprfub2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zEnHRhWnbKPd">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2022 | us-gaap |
Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
|
115000000 | usd |
CY2022 | MSSAU |
Proceeds Allocated To Public Rights
ProceedsAllocatedToPublicRights
|
-8510000 | usd |
CY2022 | MSSAU |
Proceeds Allocated To Public Warrants
ProceedsAllocatedToPublicWarrants
|
-5290000 | usd |
CY2022 | MSSAU |
Allocation Of Offering Costs Related To Ordinary Shares
AllocationOfOfferingCostsRelatedToOrdinaryShares
|
-5020172 | usd |
CY2022 | us-gaap |
Accretion Expense
AccretionExpense
|
18820172 | usd |
CY2022 | MSSAU |
Subsequent Measurement Of Class Ordinary Shares Subject To Possible Redemption Interest Earned And Unrealized Gain On Trust Account
SubsequentMeasurementOfClassOrdinarySharesSubjectToPossibleRedemptionInterestEarnedAndUnrealizedGainOnTrustAccount
|
1673481 | usd |
CY2022Q2 | MSSAU |
Related Party Service Fee
RelatedPartyServiceFee
|
10000 | usd |
CY2022 | us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
88333 | usd |
CY2021Q4 | MSSAU |
Promissory Note Related Party
PromissoryNoteRelatedParty
|
300000 | usd |
CY2021Q2 | us-gaap |
Convertible Debt
ConvertibleDebt
|
1500000 | usd |
CY2021Q2 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
10.00 | |
CY2021Q2 | us-gaap |
Convertible Debt
ConvertibleDebt
|
1500000 | usd |
CY2022Q3 | MSSAU |
Deferred Underwriting Commissions
DeferredUnderwritingCommissions
|
2875000 | usd |
CY2021Q4 | MSSAU |
Deferred Underwriting Commissions
DeferredUnderwritingCommissions
|
0 | usd |
CY2022 | us-gaap |
Professional Fees
ProfessionalFees
|
25000 | usd |
CY2022 | MSSAU |
Monthly Payment Description
MonthlyPaymentDescription
|
The Company enter into the agreement with monthly retainer of $5,000 starting form April 1, 2022 | |
CY2022Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
45000 | usd |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022 | us-gaap |
Common Stock Voting Rights
CommonStockVotingRights
|
Holders of the ordinary shares are entitled to one vote for each ordinary share. | |
CY2022Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3205000 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
3205000 | shares |
CY2022Q2 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
11500000 | shares |